A Wake Prone Positioning in Non-intubated Patients With Acute Hypoxemic Respiratory Failure

Sponsor
Montaser Gamal Ahmed (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05698004
Collaborator
(none)
244
2
14

Study Details

Study Description

Brief Summary

Patients admitted to the ICU with severe hypoxemia are at high risk for mortality. Few therapies have been proven to improve patient outcomes or duration of mechanical ventilation e.g. low tidal volume ventilation, prone positioning, and a fluid-restrictive strategy. Prone positioning is a technique used to help patients with acute respiratory distress syndrome breathe better. There is high degree of uncertainty on its effects on clinical outcomes in non-intubated patients with acute hypoxemia and larger studies are needed.

Condition or Disease Intervention/Treatment Phase
  • Other: prone positioning
N/A

Detailed Description

we plan to study the effect of prone positioning versus standard treatment in non-intubated patients with acute hypoxemia admitted at Respiratory Intensive Care Unit (RICU), Chest Department, Assiut University Hospital, Egypt.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
244 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Intervention Model Description:
Patients with acute hypoxemic respiratory failure attending the participating centres will receive either prone positioning + standard treatment or standard treatment only. All new acute hypoxemic respiratory failure patients will receive prone positioning + standard treatment for the first two weeks of the study. During the following two weeks, all new patients will receive standard treatment only. These cycles will be repeated until completion the study.Patients with acute hypoxemic respiratory failure attending the participating centres will receive either prone positioning + standard treatment or standard treatment only. All new acute hypoxemic respiratory failure patients will receive prone positioning + standard treatment for the first two weeks of the study. During the following two weeks, all new patients will receive standard treatment only. These cycles will be repeated until completion the study.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Wake Prone Positioning in Non-intubated Patients With Acute Hypoxemic Respiratory Failure
Anticipated Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Apr 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Group-1: prone positioning + standard treatment

Patients randomized to the intervention group will be subjected to awake prone positioning. The target duration of prone positioning is 8 h/d to 10 h/d with 2 to 3 breaks (1-2 hours each), if needed. Daily prone positioning sessions will be protocolized to continue until 1 of the following stopping criteria is met: a relative improvement in the FIO2 requirement by 40% from the baseline value that sustained for 24 hours; endotracheal intubation; or discharge from the ICU. The treating team will supervise patients who could move themselves during the prone positioning process and assist the patients with positioning as required.

Other: prone positioning
The target duration of prone positioning is 8 h/d to 10 h/d with 2 to 3 breaks (1-2 hours each), if needed. Daily prone positioning sessions will be protocolized to continue until 1 of the following stopping criteria is met: a relative improvement in the FIO2 requirement by 40% from the baseline value that sustained for 24 hours; endotracheal intubation; or discharge from the ICU.

No Intervention: Group-2: Standard treatment only

Patients randomized to the control group, and their treating team, will be informed of their group assignment. Nurses instruct patients not to position themselves in the prone position.

Outcome Measures

Primary Outcome Measures

  1. Number of participants within intervention arm whom need endotracheal intubation. [30 days of randomization.]

    Intubation is needed when one major criterion including (cardiac or respiratory arrest; hemodynamic instability, life threatening arrhythmias, inability to protect the airway; coma or psychomotor agitation and intolerance to NIV interface; and two of the following minor criteria: RR> 35/min., PaO2/FiO2<200 mmHg, and respiratory acidosis (pH<7.30)).

Secondary Outcome Measures

  1. Number of days on a ventilator. [30 days of randomization.]

    weaning considered successful if patient is able to achieve the following within 48 hours: pH >7.35, Decrease in PaCO2 of >15-20%, PaO2>60 mmHg, SaO2> 90% on FiO2 <40%, Respiratory rate < 24 bpm and No signs of respiratory distress like agitation, diaphoresis or anxiety.

  2. mortality. [60 days of randomization.]

  3. Length of ICU stay in days. [60 days of randomization.]

    duration of ICU stay from time of admission till discharge from ICU in days.

  4. Length of hospital stay in days. [60 days of randomization.]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients aged 18 years or older who are not intubated and required at least 40% oxygen (via low- or high-flow oxygen devices) or noninvasive positive pressure ventilation.
Exclusion Criteria: Patients will be excluded from the study if they :

had received invasive mechanical ventilation, had contraindications to prone positioning, are at risk of complications from prone positioning, had been self-prone positioning prior to enrollment and Pregnancy.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Montaser Gamal Ahmed

Investigators

  • Principal Investigator: Sahar Refaat Mahmoud, Assuit university hospital
  • Principal Investigator: Sarah Mohamed Hashem Hamza., Assuit university hospital
  • Principal Investigator: Emad Zareef, Assuit university hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Montaser Gamal Ahmed, lecturer, Assiut University
ClinicalTrials.gov Identifier:
NCT05698004
Other Study ID Numbers:
  • prone positioning in ICU
First Posted:
Jan 26, 2023
Last Update Posted:
Jan 26, 2023
Last Verified:
Dec 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 26, 2023